Article Text

Download PDFPDF
Haemophagocytic lymphohistiocytosis secondary to brucellosis in a young child
  1. Jashan Mittal1,
  2. Prawin Kumar1,
  3. Jagdish Prasad Goyal1 and
  4. Abhishek Purohit2
  1. 1Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, India
  2. 2Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Jodhpur, India
  1. Correspondence to Dr Prawin Kumar; drprawin484{at}gmail.com

Abstract

Brucellosis is a common zoonotic disease worldwide. It has protean clinical manifestation and sometimes may has a life-threatening complication. A 4-year-old boy presented with a history of fever, myalgia and appetite loss for 3 weeks. On examination, he had hepatosplenomegaly. The initial working diagnosis was an infection, autoimmune disease and malignancy. Investigations showed positive Brucella serology, and he was started on rifampicin and cotrimoxazole. He was further investigated because of persistent fever, which revealed evidence of haemophagocytic lymphohistiocytosis (HLH). He continued treatment for brucellosis, except rifampicin which was replaced with doxycyclin due to a worsening liver function. The child showed complete clinical and biochemical improvement after 6 weeks of therapy. HLH is a life-threatening condition and should be suspected in children with brucellosis, who did not respond to appropriate antibiotics treatment. Secondary HLH does not always require specific therapy; it may improve with adequate treatment of the underlying condition.

  • tropical medicine (infectious disease)
  • paediatric prescribing
  • haematology (incl blood transfusion)

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors PK and JPG: conceptualise and design the manuscript. JM: involved in the data collection and preparation of the initial draft. AP: involved in the acquisition and formatting pathological image, and writing the initial draft. All the authors were involved in the editing and critical review of the manuscript and gave final approval for the submission. PK will act as a guarantor for this manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Parental/guardian consent obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.